CellCarta expands its biomarker capabilities for clinical tria...
- Written by LATEST ASIANET NEWS RELEASES
- Published in Asia Net
MONTREAL, Aug. 31, 2021 /PRNewswire-AsiaNet/ -- CellCarta and Olink Proteomics AB announced today a strategic collaboration to offer Olink(R) Target 96 & Target 48 to pharmaceutical and biotech customers, advancing targeted protein biomarker quantification in clinical studies.Logo - https:/...
Authors: LATEST ASIANET NEWS RELEASES